- What happened
- Anthropic bought Mistral Medicine, founded by Cody Tranbarger, in July and announced the deal Tuesday. Tranbarger used Claude to take a muscle disease treatment from idea to mouse tests, managing work at 11 outside labs, and got promising results in mice in under eighteen months.
- The claim
- Anthropic says human trials could start by late 2028 if results hold. It also says it partnered with six groups on new medicines and that at one, Claude cut paperwork review time by 89%.
- Austin's take
- Austin is fired up, seeing it as a sign of a new economy of one or two person companies doing serious work with AI agents, and the reason he pushes people to learn these tools.
- Why it matters
- It hints that one person with AI can run work that used to need a whole company, even in drug development.
- What to do
- Treat this as an early signal, not proof. If you have a side project, consider where AI could coordinate work you could not afford to staff.
- Not confirmed yet
- The mouse test was small and not yet peer reviewed, and many drugs that help mice fail in people.
From the Wednesday, October 28 show
Anthropic buys a one-person drug startup built with Claude
AI-generated from the transcript